Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanoma (Q73821856)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 October 1997
edit
Language Label Description Also known as
English
Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanoma
scientific article published on 01 October 1997

    Statements

    Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanoma (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit